{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:41:10Z","timestamp":1794865270637,"version":"4.9.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijpddr.2021.09.001","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T02:52:27Z","timestamp":1632192747000},"page":"128-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Treatment of human intestinal cryptosporidiosis: A review of published clinical trials"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-0923","authenticated-orcid":false,"given":"Ajib","family":"Diptyanusa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ika Puspa","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2021.09.001_bib1","first-page":"683","article-title":"Assessing the efficacy of nitazoxanide in treatment of cryptosporidiosis using PCR examination","volume":"46","author":"Abaza","year":"2016","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216040","article-title":"Efficiency of chlorine and UV in the inactivation of Cryptosporidium and Giardia in wastewater","volume":"14","author":"Adeyemo","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib3","doi-asserted-by":"crossref","DOI":"10.1051\/parasite\/2020025","article-title":"Cryptosporidiosis in HIV-positive patients and related risk factors: a systematic review and meta-analysis","volume":"27","author":"Ahmadpour","year":"2020","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib4","doi-asserted-by":"crossref","DOI":"10.4172\/2329-9088.1000198","article-title":"Treatment outcomes with nitazoxanide in immunocompetent adults naive patients with cryptosporidiosis; do we need combination therapy with paromomycin or azithromycin?","volume":"3","author":"Ali","year":"2015","journal-title":"Trop Med Surg"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2334-9-195","article-title":"High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial","volume":"9","author":"Amadi","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1179\/joc.1999.11.5.391","article-title":"Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections","volume":"11","author":"Amenta","year":"1999","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009057","article-title":"Use-case scenarios for an anti-Cryptosporidium therapeutic","volume":"15","author":"Ashigbie","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib9","article-title":"Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum","volume":"13","author":"Bai","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00718-18","article-title":"Amixicile reduces severity of cryptosporidiosis but does not have in vitro activity against cryptosporidium","volume":"62","author":"Bartelt","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib11","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.02460-12","article-title":"Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth","volume":"57","author":"Bessoff","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/clinids\/18.3.447","article-title":"Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS","volume":"18","author":"Bissuel","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1258\/0956462971919543","article-title":"Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis","volume":"8","author":"Blanshard","year":"1997","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00076-12","article-title":"Cryptosporidium pathogenicity and virulence","volume":"26","author":"Bouzid","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-9748-0_11","article-title":"A novel method to silence genes in cryptosporidium","volume":"2052","author":"Castellanos-Gonzalez","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib16","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1038\/s41598-019-48544-z","article-title":"Systematic gene silencing identified Cryptosporidium nucleoside diphosphate kinase and other molecules as targets for suppression of parasite proliferation in human intestinal cells","volume":"9","author":"Castellanos-Gonzalez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib17","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/infdis\/jit327","article-title":"A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis","volume":"208","author":"Castellanos-Gonzalez","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-115-9-705","article-title":"Effect of octreotide on refractory AIDS-associated diarrhea","volume":"115","author":"Cello","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib19","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s00436-019-06445-0","article-title":"Identification of adaptive inhibitors of Cryptosporidium parvum fatty acyl-coenzyme A synthetase isoforms by virtual screening","volume":"118","author":"Chattopadhyay","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpara.2020.01.006","article-title":"Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned","volume":"50","author":"Choi","year":"2020","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/gut.29.5.593","article-title":"Cryptosporidial diarrhoea in AIDS and its treatment","volume":"29","author":"Connolly","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2009.80.1060","article-title":"High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control study","volume":"80","author":"Dillingham","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jcp.51.2.138","article-title":"Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin","volume":"51","author":"Dionisio","year":"1998","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1997.56.637","article-title":"Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa","volume":"56","author":"Doumbo","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM199503303321304","article-title":"The infectivity of Cryptosporidium parvum in healthy volunteers","volume":"332","author":"DuPont","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2307\/3282595","article-title":"Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves","volume":"75","author":"Fayer","year":"1989","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/clind\/16.2.298","article-title":"Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS","volume":"16","author":"Fichtenbaum","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9343(97)89499-5","article-title":"Prospective trial of paromomycin for cryptosporidiosis in AIDS","volume":"100","author":"Flanigan","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/00365520500380817","article-title":"ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea","volume":"41","author":"Flor\u00e9n","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2307\/3283792","article-title":"Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system","volume":"82","author":"Forney","year":"1996","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1556\/1886.2019.00019","article-title":"Cryptosporidium infection: epidemiology, pathogenesis, and differential diagnosis","volume":"9","author":"Gerace","year":"2019","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/38.3.399","article-title":"In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum","volume":"38","author":"Giacometti","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00002030-199207000-00015","article-title":"Vapreotide, a somatostatin analogue, in cryptosporidiosis and other AIDS-related diarrhoeal diseases","volume":"6","author":"Girard","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib35","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.02075-13","article-title":"Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis","volume":"58","author":"Gorla","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00042560-199612010-00008","article-title":"Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS","volume":"13","author":"Greenberg","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00002030-199408000-00011","article-title":"A phase I study of letrazuril in AIDS-related cryptosporidiosis","volume":"8","author":"Harris","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/318155","article-title":"Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group","volume":"31","author":"Hewitt","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-3476(96)70258-5","article-title":"Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus","volume":"129","author":"Hicks","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/AAC.01159-06","article-title":"Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni","volume":"51","author":"Hoffman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2015.09.002","article-title":"Therapeutic effects of acetylspiramycin and garlicin on cryptosporidiosis among drug users","volume":"5","author":"Huang","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib42","first-page":"463","article-title":"Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children","volume":"43","author":"Hussien","year":"2013","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4292\/wjgpt.v8.i4.201","article-title":"Protozoan parasites in irritable bowel syndrome: a case-control study","volume":"8","author":"Jadallah","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Therapeut"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exppara.2014.11.003","article-title":"Target validation of the inosine monophosphate dehydrogenase (IMPDH) gene in Cryptosporidium using Phylomer(\u00ae) peptides","volume":"148","author":"Jefferies","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib45","first-page":"425","article-title":"Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS","volume":"88","author":"Jordan","year":"1996","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib46","first-page":"179","article-title":"Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease","volume":"48","author":"Kadappu","year":"2002","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib47","first-page":"134","article-title":"Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS","volume":"22","author":"Katz","year":"1988","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib48","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2214-109X(18)30283-3","article-title":"Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study","volume":"6","author":"Khalil","year":"2018","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib50","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.bmcl.2014.07.049","article-title":"Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase","volume":"24","author":"Kumar","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/1120009X.1992.11739182","article-title":"Octreotide treatment in secretory and cryptosporidial diarrhea in patients with acquired immunodeficiency syndrome (AIDS): clinical evaluation","volume":"4","author":"Liberti","year":"1992","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00042560-199509000-00007","article-title":"Treatment with letrazuril of refractory cryptosporidial diarrhea complicating AIDS","volume":"10","author":"Loeb","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199407213310304","article-title":"A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply","volume":"331","author":"Mac Kenzie","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib55","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/165.4.772","article-title":"Paromomycin inhibits cryptosporidium infection of a human enterocyte cell line","volume":"165","author":"Marshall","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1179\/joc.1998.10.6.474","article-title":"Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: case report","volume":"10","author":"Matteelli","year":"1998","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1542\/peds.144.2MA6.592","article-title":"Cryptosporidium enteritis in an immunosuppressed child: applying the adult HIV treatment regimen","volume":"144","author":"McCann","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/infdis\/161.1.108","article-title":"A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS","volume":"161","author":"McMeeking","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(76)80331-9","article-title":"Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient","volume":"70","author":"Meisel","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.01208","article-title":"Drug development against the major diarrhea-causing parasites of the small intestine, cryptosporidium and giardia","volume":"6","author":"Miyamoto","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213752","article-title":"Accounting for long-term manifestations of Cryptosporidium spp infection in burden of disease and cost-of-illness estimations, The Netherlands (2013-2017)","volume":"14","author":"Monge","year":"2019","journal-title":"PloS One"},{"issue":"Suppl. 1","key":"10.1016\/j.ijpddr.2021.09.001_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000201073","article-title":"Treatment of AIDS-related refractory diarrhoea with octreotide","volume":"54","author":"Moroni","year":"1993","journal-title":"Digestion"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/ml100096t","article-title":"Discovery of potent and selective inhibitors of calcium-dependent protein kinase 1 (CDPK1) from C. Parvum and T. Gondii","volume":"1","author":"Murphy","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib64","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1128\/AAC.00734-13","article-title":"A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection","volume":"57","author":"Ndao","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib65","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0016-5085(76)80503-3","article-title":"Acute enterocolitis in a human being infected with the protozoan Cryptosporidium","volume":"70","author":"Nime","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00002030-199006000-00015","article-title":"Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients","volume":"4","author":"Nord","year":"1990","journal-title":"AIDS"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib67","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/QAD.0b013e3283437e88","article-title":"Cryptosporidiosis in patients with HIV\/AIDS","volume":"25","author":"O'Connor","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib68","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0264-410X(98)00477-0","article-title":"Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein","volume":"17","author":"Perryman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00210962","article-title":"A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea","volume":"71","author":"Plettenberg","year":"1993","journal-title":"Clin. Invest."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib70","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/infdis\/163.6.1293","article-title":"Activity of azithromycin against cryptosporidia in immunosuppressed rats","volume":"163","author":"Rehg","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib71","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/00002030-199112000-00012","article-title":"Efficacy of octreotide in the management of chronic diarrhoea in AIDS","volume":"5","author":"Romeu","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib72","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2036.2006.03033.x","article-title":"Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients","volume":"24","author":"Rossignol","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/321008","article-title":"Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib74","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0035-9203(98)90804-5","article-title":"A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico","volume":"92","author":"Rossignol","year":"1998","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cgh.2005.12.020","article-title":"Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species","volume":"4","author":"Rossignol","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib76","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00184800","article-title":"Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum","volume":"70","author":"Rump","year":"1992","journal-title":"Clin. Invest."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib77","first-page":"136","article-title":"Spiramycin vs. placebo for treatment of acute diarrhea caused by Cryptosporidium","volume":"8","author":"S\u00e1ez-Llorens","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40475-015-0057-8","article-title":"Challenges and innovative strategies to interrupt cryptosporidium transmission in resource-limited settings","volume":"2","author":"Samie","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QCO.0b013e328357e569","article-title":"Burden of disease from cryptosporidiosis","volume":"25","author":"Shirley","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib80","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/cid\/ciu065","article-title":"Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial","volume":"58","author":"Sindhu","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib81","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1179\/136485911X12899838683160","article-title":"In a trial of the use of miltefosine to treat HIV-related cryptosporidiosis in Zambian adults, extreme metabolic disturbances contribute to high mortality","volume":"105","author":"Sinkala","year":"2011","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib82","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1086\/515352","article-title":"Combination drug therapy for cryptosporidiosis in AIDS","volume":"178","author":"Smith","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40475-015-0056-9","article-title":"Treatment of cryptosporidium: what we know, gaps, and the way forward","volume":"2","author":"Sparks","year":"2015","journal-title":"Curr Trop Med Rep"},{"issue":"Suppl. B","key":"10.1016\/j.ijpddr.2021.09.001_bib84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/41.suppl_2.85","article-title":"AIDS-related cryptosporidial diarrhoea: an open study with roxithromycin","volume":"41","author":"Sprinz","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib85","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4161\/hv.24078","article-title":"Hyperimmune bovine colostrum for treatment of GI infections","volume":"9","author":"Steele","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib86","first-page":"183","article-title":"Clofazimine for treatment of cryptosporidiosis in human immunodeficiency virus infected adults: an experimental medicine, randomized, double-blind, placebo-controlled phase 2a trial","volume":"73","author":"Tam","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. B","key":"10.1016\/j.ijpddr.2021.09.001_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/41.suppl_2.93","article-title":"Roxithromycin treatment for diarrhoea caused by Cryptosporidium spp. in patients with AIDS","volume":"41","author":"Uip","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib88","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s15010-020-01426-3","article-title":"A review of outbreaks of cryptosporidiosis due to unpasteurized milk","volume":"48","author":"Ursini","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib89","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/14728222.2020.1785432","article-title":"Novel drug targets for treatment of cryptosporidiosis","volume":"24","author":"Wang","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ijpddr.2021.09.001_bib90","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/infdis\/170.2.419","article-title":"Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial","volume":"170","author":"White","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib91","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/infdis\/159.1.131","article-title":"Spiramycin is not effective in treating cryptosporidium diarrhea in infants: results of a double-blind randomized trial","volume":"159","author":"Wittenberg","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib93","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00004836-198712000-00005","article-title":"Treatment of cryptosporidiosis with spiramycin in AIDS. An \u201cN of 1\u201d trial","volume":"9","author":"Woolf","year":"1987","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ijpddr.2021.09.001_bib92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2036.2002.01182.x","article-title":"Albendazole chemotherapy for AIDS-related diarrhoea in Zambia--clinical, parasitological and mucosal responses","volume":"16","author":"Zulu","year":"2002","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:51:40Z","timestamp":1761922300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320721000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":93,"alternative-id":["S2211320721000440"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.09.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of human intestinal cryptosporidiosis: A review of published clinical trials","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}